Vancomycin
Drugadult patients treated with intravenous vancomycin in intensive care unit
NCT Number: NCT03806543
The aim of this study was to assess factors that may influence vancomycin trough level and the rate achieving the target trough level in critically ill patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
This retrospective observational study included adult patients treated with intravenous vancomycin in intensive care unit of Zhongda Hospital from January 2015 to December 2017. Vancomycin dose was based on international consensus and adjusted according to estimated glomerular filtration rate (eGFR) calculated by the Cockcroft-Gault equation. vancomycin trough level (VTL) was retained at steady state (after the third dose). Linear regression was performed to determine the correlation between factors prior to the first vancomycin dose and VTL. Distribution of VTL and percentage of patients achieving the target trough level (15-20mg/L) was observed in different renal function.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
adult patients treated with intravenous vancomycin in intensive care unit
Time frame: 3 years
Vancomycin trough level was retained at steady state (after the third dose). If a patient has multiple measurements of vancomycin trough level, the first measurement is collected.Rate of patients achieving the target trough level (15-20mg/L) was observed.
Southeast University, China
Other
The Influencing Factors of Vancomycin Trough Level and the Rate Achieving the Target Trough Level in Critically Ill Patients: A Retrospective Observational Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06069206
Bloodstream Infection, Infections
Nashville, Tennessee, United States
View Trial DetailsNCT04666948
Vancomycin
Brussels, Brussels Capital, Belgium
View Trial DetailsNCT05823116
Acute Kidney Injury, Female Urogenital Diseases
Lexington, Kentucky, United States
View Trial DetailsNCT04911270
Bacterial Infections, Bacterial Infections and Mycoses
Baltimore, Maryland, United States
View Trial Details